Metraipolis › archive › dc_2d61e97ec015
Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study… — Europe PMC PMID:42015349
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42015349
- DOI
- 10.1080/15384047.2026.2662031
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T08:06:29.193Z
- SHA-256 of the archived text
17daff6d03f1f7c73e03159b5961c57feafe1cc85b1adee916726d73e0666cf9- Stable URL of this page
https://metraipolis.com/documento/dc_2d61e97ec015
How to cite
Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study… — Europe PMC PMID:42015349 — Europe PMC (en), https://europepmc.org/article/MED/42015349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d61e97ec015 (Metraipolis archive dc_2d61e97ec015, sha256 17daff6d03f1f7c73e03159b5961c57feafe1cc85b1adee916726d73e0666cf9)
BibTeX
@misc{dc2d61e97ec015,
title = {Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study… — Europe PMC PMID:42015349},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42015349},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d61e97ec015; sha256 17daff6d03f1f7c73e03159b5961c57feafe1cc85b1adee916726d73e0666cf9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42015349. Agents can read the archived copy with the MCP tool read_document.